Thomas Bello

Computational Biologist II at Adaptive Biotechnologies

Thomas Bello is a skilled computational biologist with extensive experience in both academic and industry settings. Currently, Thomas serves as a Computational Biologist II at Adaptive Biotechnologies Corp., after progressing from Computational Biologist I. Previous roles include Postdoctoral Researcher at Fred Hutch and Graduate Student Researcher at the University of Washington, where significant contributions include the development of the KInhibition web application and research on kinase signaling in prostate cancer. Thomas's background also includes a biotechnology externship at Omeros Corporation, undergraduate research in biomedical imaging, and a strong educational foundation with a PhD in Cell/Cellular and Molecular Biology from the University of Washington, alongside dual bachelor’s degrees in Biomedical Engineering and Mathematics from the University of Arizona.

Location

Seattle, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices


Adaptive Biotechnologies

17 followers

Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems. Adaptive’s proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with unprecedented scale and precision.


Employees

501-1,000

Links